Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves …
Over the last 12 months, insiders at Accolade, Inc. have bought $0 and sold $2.51M worth of Accolade, Inc. stock.
On average, over the past 5 years, insiders at Accolade, Inc. have bought $178,758 and sold $4.25M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 74 shares for transaction amount of $743 was made by Barnes Stephen H. (Chief Financial Officer) on 2022‑08‑02.
2024-12-17 | Sale | Chief Executive Officer | 381 0.0005% | $3.43 | $1,308 | +2.35% | ||
2024-12-17 | Sale | Chief Financial Officer | 123 0.0002% | $3.43 | $422 | +2.35% | ||
2024-12-17 | Sale | President | 156 0.0002% | $3.43 | $535 | +2.35% | ||
2024-12-11 | Sale | Chief Executive Officer | 667 0.0008% | $3.62 | $2,416 | -4.92% | ||
2024-12-11 | Sale | Chief Financial Officer | 222 0.0003% | $3.62 | $804 | -4.92% | ||
2024-12-11 | Sale | President | 214 0.0003% | $3.62 | $775 | -4.92% | ||
2024-12-03 | Sale | Chief Executive Officer | 13,357 0.0165% | $3.60 | $48,018 | -1.12% | ||
2024-12-03 | Sale | Chief Financial Officer | 5,640 0.007% | $3.60 | $20,276 | -1.12% | ||
2024-12-03 | Sale | President | 5,582 0.0069% | $3.60 | $20,067 | -1.12% | ||
2024-12-03 | Sale | EVP General Counsel | 3,581 0.0044% | $3.60 | $12,874 | -1.12% | ||
2024-12-03 | Sale | Chief Accounting Officer | 2,388 0.003% | $3.60 | $8,585 | -1.12% | ||
2024-11-19 | Sale | Chief Executive Officer | 380 0.0005% | $3.35 | $1,271 | +5.38% | ||
2024-11-19 | Sale | Chief Financial Officer | 121 0.0001% | $3.35 | $405 | +5.38% | ||
2024-11-19 | Sale | President | 154 0.0002% | $3.35 | $515 | +5.38% | ||
2024-11-12 | Sale | Chief Executive Officer | 668 0.0008% | $3.64 | $2,430 | -2.16% | ||
2024-11-12 | Sale | Chief Financial Officer | 223 0.0003% | $3.64 | $811 | -2.16% | ||
2024-11-12 | Sale | President | 214 0.0003% | $3.64 | $779 | -2.16% | ||
2024-11-04 | Sale | Chief Executive Officer | 1,545 0.0019% | $3.15 | $4,865 | +14.92% | ||
2024-11-04 | Sale | Chief Financial Officer | 458 0.0006% | $3.15 | $1,442 | +14.92% | ||
2024-11-04 | Sale | President | 475 0.0006% | $3.15 | $1,496 | +14.92% |
SINGH RAJEEV | Chief Executive Officer | 815851 1.013% | $3.48 | 1 | 68 | +16.34% |
Barnes Stephen H. | Chief Financial Officer | 220463 0.2737% | $3.48 | 2 | 67 | +16.34% |
Brown Advisory | $61.27M | 7.42 | 5.85M | -1.96% | -$1.22M | 0.08 | |
BlackRock | $59.33M | 7.18 | 5.66M | +<0.01% | +$2,378.96 | <0.01 | |
ARK Investment Management LLC | $58.82M | 7.12 | 5.61M | -17.52% | -$12.49M | 0.2 | |
The Vanguard Group | $56.63M | 6.85 | 5.4M | +1.45% | +$807,421.12 | <0.01 | |
JPMorgan Chase | $55.87M | 6.76 | 5.33M | -16.83% | -$11.31M | 0.01 |